FDA label
What is Intrarosa used for?
Intrarosa contains prasterone. The FDA-approved uses below are quoted from the Indications and Usage section of its DailyMed label.
Source: DailyMed SPL label file dated 2026-10-23. Publisher page
The FDA label says: “INTRAROSA® is a steroid indicated for the treatment of moderate to severe dyspareunia, a symptom of vulvar and vaginal atrophy, due to menopause.”
Run it in Rivvi
Which 2027 plans near you dropped or restricted Intrarosa?
Tier changes and new prior auth, step therapy or quantity limits, plan by plan.
Free to start. Opens Rivvi, the AI workspace for healthcare teams.
Intrarosa, insert
Indications and Usage, quoted from the label by Millicent US, Inc. (NDA208470). Cross-references to other label sections are left out.
INTRAROSA® is a steroid indicated for the treatment of moderate to severe dyspareunia, a symptom of vulvar and vaginal atrophy, due to menopause.
Source: DailyMed label, set id ada639d4-bac0-2ad0-e053-2a95a90afce7, version 9, effective July 17, 2026. NDC 72495-401, one of 2 listings for this product.
Questions
What is Intrarosa used for?
The FDA label says: “INTRAROSA® is a steroid indicated for the treatment of moderate to severe dyspareunia, a symptom of vulvar and vaginal atrophy, due to menopause.”
Does this page cover off-label uses or dosing?
No. This page shows only the Indications and Usage section of the FDA label. Ask a pharmacist or prescriber about dosing.